This study aimed to use cardiac magnetic resonance imaging (CMR) to evaluate the efficacy and
safety of bisoprolol therapy for boys with Duchenne muscular dystrophy(DMD) and preserved
ejection fraction. On top of angiotensin-converting enzyme inhibitor (ACEI) , half of the
participants will receive bisoprolol in combination, while the other half will not receive
any beta-blocker.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborators:
Chinese Academy of Medical Sciences National Natural Science Foundation of China